Increased placental growth factor (PlGF) concentrations in children and adolescents with obesity and the metabolic syndrome.

Increased placental growth factor (PlGF) concentrations in children and adolescents with obesity and the metabolic syndrome. Panagiota Pervanidou, Giorgos Chouliaras, Athanassios Akalestos, Despoina Bastaki, Filia Apostolakou, Ioannis Papassotiriou, George P. Chrousos.  HORMONES 2014, 13(3):369-374

Μοιραστείτε το

Childhood obesity and the Metabolic Syndrome (MetS) are associated with an increased risk for early onset endothelial dysfunction and atherosclerosis. Placental growth factor (PlGF), a member of the vascular endothelial growth factor family, plays an important role in atherosclerosis by stimulating angiogenesis and atherogenic migration of monocytes macrophages into the arterial wall. The aim of this study was to investigate differences in circulating PlGF concentrations between children with obesity/metabolic syndrome and non-obese children. We have previously shown increased high-sensitivity troponin (hs-TnT) concentrations in children with MetS from the same cohort.

HORMONES 2014, 13(3):369-374

Για να διαβάσετε ολόκληρο το άρθρο, πατήστε εδώ.

Εγγραφείτε στο Newsletter μας

Δείτε επίσης

Παιδιατρική Αρθρογραφία

The Impact of the Glycemic Index, Glycemic load and the Macronutrient intake of the Diet of overweight and obese Children on Metabolic Syndrome Development.

The Impact of the Glycemic Index, Glycemic load and the Macronutrient intake of the Diet of overweight and obese Children on Metabolic Syndrome Development. Niki Philippas*, Despoina Bastaki, Panagiota Pervanidou, Eleftheria Roma-Giannikou, George Chrousos, Christina Kanaka-Gantenbein. Bioaccent Journal Nutrition 

Scroll to Top